Language in Primary Progressive Aphasia
Language in Primary Progressive Aphasia
批准号:
8292779
负责人:
MAREK-MARSEL M MESULAM
金额:
$60.95万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-05 至 2017-04-30
关键词:
AddressAlzheimer&aposs DiseaseAmericanAnomiaAnteriorAphasiaArchitectureAreaAtrophicAttentionBiological MarkersBiometryBrain DiseasesBroca&aposs areaCerebrumCharacteristicsCollaborationsCompetenceComprehensionDementiaDepositionDevelopmentDiagnosisDiseaseEnrollmentEvent-Related PotentialsEvolutionEye MovementsFosteringFrequenciesFrontotemporal Lobar DegenerationsFundingGeographic DistributionGoalsGrantHeterogeneityImpairmentInternationalInvestigationLanguageLanguage DisordersLearningLeftLongitudinal StudiesMagnetic ResonanceMemoryMethodologyModalityNamesNeurobiologyNeurodegenerative DisordersNeuropsychologyParticipantPathologyPatientsPhenotypePhysicsPrimary Progressive AphasiaProcessProductivityRecoveryRecruitment ActivityRegistriesReportingResearchResearch PersonnelResourcesRetrievalRisk FactorsScheduleSemanticsServicesSiteStagingStructureSyndromeTauopathiesTemporal LobeTravelUniversitiesVariantVisitbasecerebral atrophycohortdata sharingdesignfollow-upinterdisciplinary approachinterestinternational centermultidisciplinaryneurobehaviorneuroimagingneuropathologynovelprogramsprotein TDP-43research studyweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Primary progressive aphasia (PPA) is a brain disease that causes a gradual and increasingly more debilitating impairment of word usage and comprehension. Although it is being recognized with increasing frequency, PPA remains underserved with respect to research and patient services. This application seeks continued funding for a project that is the centerpiece of a comprehensive PPA Research Program at Northwestern University. The goal is to make maximal use of a unique cohort that has been recruited during the first 5 years of the project and to enroll new patients for hypothesis-driven investigations of naming, word comprehension, incidental memory and sentence processing with novel tasks designed by a multidisciplinary team of investigators with a track record of close collaboration and high productivity in PPA. We believe that this type of research program can best be achieved within the structure of a multidisciplinary approach such as the one we have established for this purpose, led by researchers in neuroimaging (Dr. Emily Rogalski), neurolinguistics (Dr. Cynthia Thompson), event-related potentials (Dr. Ken Paller), neuropsychology (Dr. Sandra Weintraub), neurobehavior (Dr. Marsel Mesulam), biostatistics (Dr. Alfred Rademaker) and Magnetic Resonance physics (Dr. Todd Parrish). For the next cycle, we chose specific aims that address the four core themes of this project: subtyping and temporal evolution of PPA, mechanisms of naming and semantic distortions, characteristics of fluency and grammatical competence, and anatomical substrates of language as inferred from the distribution of peak atrophy sites in patients. Within this framework, our primary aims will be 1. To complete a longitudinal study of a select subset of current participants in order to delineat the natural course of PPA and to characterize the evolution of its initial stages (Experiment 1). 2 To clarify the mechanisms of anomia with a cross-modal ERP experiment (Experiment 2). 3. To investigate dynamic perturbations of verb and sentence processing with on-line tasks using the methodology of ERP and eye movement recording (Experiments 3 and 4). 4. To identify the anatomical basis of material- and modality-specific distortions of learning in PPA (Experiment 5). 5. To foster the continued development of the International PPA Connection (IMPPACT) website, launched through the American Recovery and Reinvestment Act (ARRA), as an international collaborative patient and resource registry (ppaconnection.org).
PUBLIC HEALTH RELEVANCE: Primary progressive aphasia (PPA) is a brain disease that causes a gradual and increasingly more debilitating impairment of word usage and comprehension. Although it is being recognized with increasing frequency, PPA remains underserved with respect to research and patient services. This application seeks continued funding for a project that is the centerpiece of a comprehensive PPA Research Program at Northwestern University.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA
-
批准号:10440152
-
项目类别:
-
资助金额:$208.97万
-
财政年份:2022
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA
-
批准号:10643863
-
项目类别:
-
资助金额:$205.79万
-
财政年份:2022
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
Language in Primary Progressive Aphasia
-
批准号:7850270
-
项目类别:
-
资助金额:$20.63万
-
财政年份:2009
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
Language in Primary Progressive Aphasia
-
批准号:7618180
-
项目类别:
-
资助金额:$51.44万
-
财政年份:2007
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
Language in Primary Progressive Aphasia
-
批准号:7179626
-
项目类别:
-
资助金额:$37.19万
-
财政年份:2007
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
Language in Primary Progressive Aphasia
-
批准号:8066356
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2007
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
Language in Primary Progressive Aphasia
-
批准号:7407382
-
项目类别:
-
资助金额:$43.96万
-
财政年份:2007
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
Language in Primary Progressive Aphasia
-
批准号:7826625
-
项目类别:
-
资助金额:$51.55万
-
财政年份:2007
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
Language in Primary Progressive Aphasia
-
批准号:9916775
-
项目类别:
-
资助金额:$62.07万
-
财政年份:2007
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
Language in Primary Progressive Aphasia
-
批准号:8841266
-
项目类别:
-
资助金额:$61.09万
-
财政年份:2007
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
Language in Primary Progressive Aphasia
-
批准号:8656321
-
项目类别:
-
资助金额:$62.3万
-
财政年份:2007
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
Language in Primary Progressive Aphasia
-
批准号:8466306
-
项目类别:
-
资助金额:$59.18万
-
财政年份:2007
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
ADCS/NIA PROTOCOL ACD-015: SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S
-
批准号:7604252
-
项目类别:
-
资助金额:$0.37万
-
财政年份:2006
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE
-
批准号:7604304
-
项目类别:
-
资助金额:$2.06万
-
财政年份:2006
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
ADCS/NIA PROTOCOL ACD-016: HIGH DOSE SUPPLEMENTS AND ALZHEIMER'S DISEASE
-
批准号:7604255
-
项目类别:
-
资助金额:$0.73万
-
财政年份:2006
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
ADCS/NIA PROTOCOL ACD-016: HIGH DOSE SUPPLEMENTS AND ALZHEIMER'S DISEASE
-
批准号:7376846
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2005
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE
-
批准号:7376907
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2005
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
ADCS/NIA PROTOCOL ACD-015: SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S
-
批准号:7376842
-
项目类别:
-
资助金额:$0.89万
-
财政年份:2005
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
ADCS/NIA PROTOCOL ADC-016: HIGH DOSE SUPPLEMENTS AND ALZHEIMER'S DISEASE
-
批准号:7200451
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2004
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位:
ADCS/NIA PROTOCOL ADC-015: SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S
-
批准号:7200446
-
项目类别:
-
资助金额:$0.74万
-
财政年份:2004
-
负责人:MAREK-MARSEL M MESULAM
-
依托单位: